Minireviews
World J Hepatol
9(25):1043-1053.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1043
Abstract (1232)
|
Core Tip (1218)
|
Full Article (HTML) (3836)
|
Tables (1-3) (473)
|
Full Article (PDF)-1379K (596)
|
Audio-718K (17)
|
Peer-Review Report-94K (197)
|
Answering Reviewers-128K (210)
|
Received: 05/27/2017
|
Revised: 07/13/2017
|
Accepted: 08/04/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (12896)
|
Similar Articles (384)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
9(25):1054-1063.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1054
Abstract (1290)
|
Core Tip (1084)
|
Full Article (HTML) (4393)
|
Full Article (PDF)-1369K (750)
|
Audio-468K (14)
|
Peer-Review Report-78K (253)
|
Answering Reviewers-64K (202)
|
Received: 01/26/2017
|
Revised: 07/18/2017
|
Accepted: 08/16/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (18)
|
Total Visits (13909)
|
Similar Articles (183)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions

World J Hepatol
9(25):1064-1072.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1064
Abstract (1359)
|
Core Tip (1116)
|
Full Article (HTML) (4859)
|
Figures (1-2) (443)
|
Tables (1-2) (439)
|
Full Article (PDF)-1444K (376)
|
Audio-2584K (19)
|
Peer-Review Report-98K (178)
|
Answering Reviewers-81K (152)
|
Received: 03/16/2017
|
Revised: 05/17/2017
|
Accepted: 07/17/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (17016)
|
Similar Articles (8)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients

World J Hepatol
9(25):1073-1080.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1073
Abstract (1239)
|
Core Tip (1106)
|
Full Article (HTML) (3430)
|
Figures (1-3) (438)
|
Tables (1-2) (442)
|
Full Article (PDF)-1721K (444)
|
Audio-547K (34)
|
Peer-Review Report-82K (163)
|
Answering Reviewers-134K (160)
|
Received: 01/04/2017
|
Revised: 04/29/2017
|
Accepted: 05/24/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (16550)
|
Similar Articles (124)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open